跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,875 条关于
“JH2 domain”
全部
1,875
临床试验
971
药物
183
机构
22
资讯
699
9个月前
Atavistik Bio Unveils Novel JAK2 V617F Mutant-Selective Inhibitors for Myeloproliferative Neoplasms at ASH 2025
11天前
Accro Bioscience Announces NMPA Clearance for Phase II/III Trial of AC-201, a Selective TYK2/JAK1 Inhibitor for Non-Segmental Vitiligo
9个月前
Lynk Pharmaceuticals Receives FDA IND Approval for Brain-Penetrant TYK2 Inhibitor LNK01006 Targeting Neuroinflammatory Diseases
去年
InnoCare's TYK2 Inhibitor ICP-488 Demonstrates Promising Phase II Results in Psoriasis Patients
去年
Accro Bioscience to Present Positive Phase II Results for AC-201 TYK2/JAK1 Inhibitor in Plaque Psoriasis at EADV Congress
去年
Fosun Pharma Secures Exclusive Rights to Accro's TYK2/JAK1 Inhibitor AC-201 for Greater China in $21.8M Deal
去年
Accropeutics' Oral TYK2/JAK1 Inhibitor Shows Strong Efficacy in Phase 2 Psoriasis Trial
6个月前
Leveragen Secures Japanese Patent for Singularity Platform Single-Domain Antibody Discovery Technology
去年
Recludix Unveils First-in-Class BTK SH2 Domain Inhibitor with Superior Selectivity for Chronic Spontaneous Urticaria
去年
Domain Therapeutics to Showcase Novel GPCR-Targeting Oncology Programs at AACR 2025
第 1 页,共 70 页
上一页
下一页